BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1866073)

  • 1. Long-term multicentre study on beta 2-microglobulin removal by PMMA BK membrane.
    Arakawa M
    Nephrol Dial Transplant; 1991; 6 Suppl 2():69-74. PubMed ID: 1866073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rôle of adsorption in beta 2-microglobulin removal.
    David S; Canino F; Ferrari ME; Cambi V
    Nephrol Dial Transplant; 1991; 6 Suppl 2():64-8. PubMed ID: 1866072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new polymethylmethacrylate membrane for hemodialysis.
    Bonomini M; Fiederling B; Bucciarelli T; Manfrini V; Di Ilio C; Albertazzi A
    Int J Artif Organs; 1996 Apr; 19(4):232-9. PubMed ID: 8786174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Learning from the Japanese Registry: how will we prevent long-term complications? Niigata Research Programme for beta 2-M Removal Membrane.
    Aoike I; Gejyo F; Arakawa M
    Nephrol Dial Transplant; 1995; 10 Suppl 7():7-15. PubMed ID: 8570083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
    Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S
    Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uraemic itching: do polymethylmethacrylate dialysis membranes play a role?
    Aucella F; Vigilante M; Gesuete A; Maruccio G; Specchio A; Gesualdo L
    Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v8-12. PubMed ID: 17586845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialysis arthropathy, beta 2-microglobulin and the effect of dialyser membrane.
    Sethi D; Gower PE
    Nephrol Dial Transplant; 1988; 3(6):768-72. PubMed ID: 3147418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatibility and capability of haemopurification systems: review and future development.
    Ota K
    Nephrol Dial Transplant; 1991; 6 Suppl 2():86-90. PubMed ID: 1866077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of haemodialysis membranes on beta 2-microglobulin kinetics: in vivo and in vitro studies.
    Zingraff J; Beyne P; Ureña P; Uzan M; Nguyen Khoa Man ; Descamps-Latscha B; Drüeke T
    Nephrol Dial Transplant; 1988; 3(3):284-90. PubMed ID: 3140102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term influence of dialysis treatment on beta 2-microglobulin, interleukin-2 R and tumour necrosis factor.
    Bandiani G; Camaiora E; Farina D; Nicolini MA; Perotta U; Tagliazucchi A
    Nephrol Dial Transplant; 1991; 6 Suppl 2():61-3. PubMed ID: 1866071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [What is the reason for the increase in beta-2-microglobulin levels in the blood when using cuprophane dialysis membranes?].
    Sulková S; Lapcík O; Votruba T
    Cas Lek Cesk; 1989 Apr; 128(17):520-3. PubMed ID: 2665936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical and parametric analysis of beta-2-microglobulin removal from uremic patients in high flux hemodialysis.
    Lee CJ; Hsiong CH; Chang YL; Cheng CH; Lian JD
    ASAIO J; 1994; 40(1):62-6. PubMed ID: 8186494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of protein adsorbable membranes--long-term clinical effects and analysis using a proteomic technique.
    Aoike I
    Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v13-9. PubMed ID: 17586841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of cuprophane membrane surface dialyzers on beta2-microglobulin serum concentration in patients during hemodialysis].
    Szepietowski T; el-Hayek A
    Polim Med; 1993; 23(3-4):43-54. PubMed ID: 8029157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-flux synthetic versus cellulosic membranes for beta 2-microglobulin removal during hemodialysis, hemodiafiltration and hemofiltration.
    Floege J; Granolleras C; Deschodt G; Heck M; Baudin G; Branger B; Tournier O; Reinhard B; Eisenbach GM; Smeby LC
    Nephrol Dial Transplant; 1989; 4(7):653-7. PubMed ID: 2510064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum beta 2 microglobulin and extracellular fluid volume during haemodialysis.
    Chanard J; Toupance O; Lavaud S; Jaisser F; Gillery P
    Nephrol Dial Transplant; 1989; 4(6):549-54. PubMed ID: 2507977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodialysis-associated beta 2M amyloidosis: current controversies.
    Stein G; Sperschneider H; Fünfstück R; Ritz E
    Nephrol Dial Transplant; 1994; 9 Suppl 3():48-50. PubMed ID: 8072726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R; Polkinghorne KR; Kerr PG
    Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatibility of PMMA membranes used in haemofiltration and haemodiafiltration: beta 2-microglobulin removal and release of granulocyte elastase.
    Hillion D; Haas T; Uzan M; Pertuiset N; Beyne P
    Nephrol Dial Transplant; 1991; 6 Suppl 2():84-5. PubMed ID: 1866076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.